Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Distribution

McKesson Corporation distributes pharmaceuticals, medical-surgical supplies, and health and beauty care products throughout North America. The Company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise. In addition, McKesson offers analytic, care management, and patient solutions for payers.
Website: mckesson.com



Growth: Good revenue growth rate 14.8%, there is acceleration compared to average historical growth rates 8.3%. The revenue growth dynamics is moderately stable Site traffic for the last 3 months showed a change of -2.6%

Profitability: LTM EBITDA margin is positive, +1.4%. On average the margin is decreasing steadily. Gross margin is low, +3.9%. In the last quarter the company beat the estimated EPS, +0.3%. The company was ahead of estimated EPS in 60% of quarters (showing a gain of +$0.18 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.4%. Free cash flow yield -0.3% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 190.4% higher than minimum and 0.4% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.1x by EV / Sales multiple , the company can be >100% undervalued

Insiders: For the last 3 months insiders sold company shares on $8.7 mln (-0.012% of cap.)

Key Financials (Download financials)

Ticker: MCK
Share price, USD:  (-0.4%)536.85
year average price 441.16  


year start price 356.05 2023-03-31

min close price 354.01 2023-05-01

max close price 539.26 2024-03-27

current price 536.85 2024-03-29
Common stocks: 144 395 010

Dividend Yield:  0.4%
FCF Yield LTM: -0.3%
EV / LTM EBITDA: 19.4x
EV / EBITDA annualized: 26.1x
Last revenue growth (y/y):  14.8%
Last growth of EBITDA (y/y):  -42.3%
Historical revenue growth:  8.3%
Historical growth of EBITDA:  37.3%
EV / Sales: 0.3x
Margin (EBITDA LTM / Revenue): 1.4%
Fundamental value created in LTM:
Market Cap ($m): 77 518
Net Debt ($m): 5 997
EV (Enterprise Value): 83 515
Price to Book: -37.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-03-28Zacks Investment Research

McKesson (MCK) Hits 52-Week High: What's Driving the Stock?

2024-03-27Business Wire

McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date

2024-03-22Zacks Investment Research

Here's Why You Should Hold McKesson (MCK) in Your Portfolio

2024-03-07Zacks Investment Research

Why McKesson (MCK) is a Top Value Stock for the Long-Term

2024-02-28Zacks Investment Research

Are Investors Undervaluing McKesson (MCK) Right Now?

2024-02-27Zacks Investment Research

McKesson (MCK) Hits 52-Week High: What's Driving the Stock?

2024-02-20Zacks Investment Research

Here's Why McKesson (MCK) is a Strong Value Stock

2024-02-19Seeking Alpha

McKesson: GLP-1 Contributed More Than 1/3 Of Growth

2024-02-08Zacks Investment Research

McKesson (MCK) Beats on Q3 Earnings, Raises FY24 EPS View

2024-02-07Zacks Investment Research

Here's What Key Metrics Tell Us About McKesson (MCK) Q3 Earnings
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol MCK MCK MCK MCK MCK MCK
reportedCurrency USD USD USD USD USD USD
cik 927 653 927 653 927 653 927 653 927 653 927 653
fillingDate 2024-02-08 2023-11-02 2023-08-02 2023-05-09 2023-02-02 2022-11-02
acceptedDate 2024-02-07 17:33:42 2023-11-01 17:34:34 2023-08-02 17:30:23 2023-05-08 17:46:40 2023-02-01 17:36:25 2022-11-01 17:37:42
calendarYear 2024.000 2024.000 2024.000 2023.000 2023.000 2023.000
period Q3 Q2 Q1 Q4 Q3 Q2
revenue 80 898M 77 215M 74 483M 68 910M 70 490M 70 157M
costOfRevenue 77 746M 74 146M 71 461M 65 844M 67 316M 67 062M
grossProfit 3 152M 3 069M 3 022M 3 066M 3 174M 3 095M
grossProfitRatio 0.039 0.040 0.041 0.044 0.045 0.044
researchAndDevelopmentExpenses 0 0 0 0 0 0
generalAndAdministrativeExpenses 5 012M 4 184M 3 740M 3 806M 3 806M 0
sellingAndMarketingExpenses -2 506M -2 092M -1 870M -9 782M -1 903M 1 950M
sellingGeneralAndAdministrativeExpenses 2 506M 2 092M 1 870M 1 964M 1 903M 1 950M
otherExpenses 34M 26M 38M 31M 276M 0
operatingExpenses 2 506M 2 092M 1 870M 1 964M 1 903M 1 950M
costAndExpenses 80 252M 76 238M 73 331M 67 808M 69 219M 69 012M
interestIncome 0 61M 0 0 0 0
interestExpense 64M 61M 47M 79M 69M 55M
depreciationAndAmortization 159M 157M 159M 314M 454M 347M
ebitda 839M 1 003M 1 349M 1 294M 1 695M 1 471M
ebitdaratio 0.010 0.013 0.018 0.019 0.024 0.021
operatingIncome 642M 951M 1 100M 980M 1 241M 1 124M
operatingIncomeRatio 0.008 0.012 0.015 0.014 0.018 0.016
totalOtherIncomeExpensesNet 30M -35M -14M -48M 207M 120M
incomeBeforeTax 612M 916M 1 091M 932M 1 448M 1 244M
incomeBeforeTaxRatio 0.008 0.012 0.015 0.014 0.021 0.018
incomeTaxExpense -18M 213M 94M 106M 329M 271M
netIncome 589M 664M 958M 787M 1 079M 926M
netIncomeRatio 0.007 0.009 0.013 0.011 0.015 0.013
eps 4.450 4.950 7.070 5.750 7.710 6.470
epsdiluted 4.420 4.920 7.020 5.710 7.660 6.420
weightedAverageShsOut 133M 134M 136M 137M 140M 143M
weightedAverageShsOutDil 133M 135M 137M 138M 141M 144M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol MCK MCK MCK MCK MCK MCK
reportedCurrency USD USD USD USD USD USD
cik 927 653 927 653 927 653 927 653 927 653 927 653
fillingDate 2024-02-08 2023-11-02 2023-08-02 2023-05-09 2023-02-02 2022-11-02
acceptedDate 2024-02-07 17:33:42 2023-11-01 17:34:34 2023-08-02 17:30:23 2023-05-08 17:46:40 2023-02-01 17:36:25 2022-11-01 17:37:42
calendarYear 2024.000 2024.000 2024.000 2023.000 2023.000 2023.000
period Q3 Q2 Q1 Q4 Q3 Q2
cashAndCashEquivalents 1 982M 2 524M 2 636M 4 678M 2 774M 2 916M
shortTermInvestments 0 0 0 0 0 0
cashAndShortTermInvestments 1 982M 2 524M 2 636M 4 678M 2 774M 2 916M
netReceivables 23 066M 22 494M 21 860M 19 410M 20 537M 20 109M
inventory 22 020M 21 945M 20 510M 19 691M 20 657M 19 876M
otherCurrentAssets 572M 568M 533M 496M 689M 3 547M
totalCurrentAssets 47 640M 47 531M 45 539M 44 292M 44 657M 46 448M
propertyPlantEquipmentNet 3 880M 3 851M 3 865M 3 812M 3 793M 3 619M
goodwill 9 973M 9 934M 9 971M 9 947M 9 934M 9 239M
intangibleAssets 2 097M 2 142M 2 221M 2 277M 2 273M 1 872M
goodwillAndIntangibleAssets 12 070M 12 076M 12 192M 12 224M 12 207M 11 111M
longTermInvestments 351M 295M 0 0 0 0
taxAssets -351M -295M 0 0 0 0
otherNonCurrentAssets 2 922M 2 633M 2 500M 1 992M 2 033M 1 903M
totalNonCurrentAssets 18 872M 18 560M 18 557M 18 028M 18 033M 16 633M
otherAssets 0 0 0 0 0 0
totalAssets 66 512M 66 091M 64 096M 62 320M 62 690M 63 081M
accountPayables 46 699M 46 795M 43 982M 42 490M 42 238M 41 003M
shortTermDebt 562M 345M 350M 1 267M 1 313M 1 084M
taxPayables 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0
otherCurrentLiabilities 4 400M 4 007M 4 090M 4 200M 4 455M 6 270M
totalCurrentLiabilities 51 661M 51 147M 48 422M 47 957M 48 006M 48 357M
longTermDebt 7 046M 6 971M 7 073M 6 028M 6 862M 6 128M
deferredRevenueNonCurrent 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 978M 1 112M 1 139M 1 387M 1 465M 1 660M
otherNonCurrentLiabilities 8 509M 8 325M 8 702M 8 438M 8 446M -26 114M
totalNonCurrentLiabilities 16 533M 16 408M 16 914M 15 853M 16 773M 15 973M
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 1 717M 1 732M 1 762M 1 701M 1 702M 1 599M
totalLiabilities 68 194M 67 555M 65 336M 63 810M 64 779M 64 330M
preferredStock 0 0 0 0 0 0
commonStock 3M 3M 3M 3M 3M 3M
retainedEarnings 14 268M 13 761M 13 182M 12 295M 11 582M 10 579M
accumulatedOtherComprehensiveIncomeLoss -812M -887M -848M -905M -899M -1 114M
othertotalStockholdersEquity -15 512M -14 705M -13 939M -13 250M -13 141M -11 235M
totalStockholdersEquity -2 053M -1 828M -1 602M -1 857M -2 455M -1 767M
totalEquity -1 682M -1 464M -1 240M -1 857M -2 455M -1 767M
totalLiabilitiesAndStockholdersEquity 66 512M 66 091M 64 096M 62 320M 62 690M 63 081M
minorityInterest 371M 364M 362M 367M 366M 0
totalLiabilitiesAndTotalEquity 66 512M 66 091M 64 096M 62 320M 62 690M 63 081M
totalInvestments 351M 295M 0 0 0 0
totalDebt 7 608M 7 316M 7 423M 7 295M 8 175M 7 212M
netDebt 5 626M 4 792M 4 787M 2 617M 5 401M 4 296M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol MCK MCK MCK MCK MCK MCK
reportedCurrency USD USD USD USD USD USD
cik 927 653 927 653 927 653 927 653 927 653 927 653
fillingDate 2024-02-08 2023-11-02 2023-08-02 2023-05-09 2023-02-02 2022-11-02
acceptedDate 2024-02-07 17:33:42 2023-11-01 17:34:34 2023-08-02 17:30:23 2023-05-08 17:46:40 2023-02-01 17:36:25 2022-11-01 17:37:42
calendarYear 2024.000 2024.000 2024.000 2023.000 2023.000 2023.000
period Q3 Q2 Q1 Q4 Q3 Q2
netIncome 630M 703M 997M 826M 1 120M 967M
depreciationAndAmortization 159M 157M 159M 161M 148M 151M
deferredIncomeTax -281M -36M -235M -75M -115M 61M
stockBasedCompensation 45M 46M 875M 0 0 0
changeInWorkingCapital -968M -254M -2 113M 2 132M 406M -8M
accountsReceivables -1 091M -827M -2 380M 502M 0 0
inventory -35M -1 523M -826M 931M -737M -498M
accountsPayables -144M 2 834M 1 473M 2 782M 0 0
otherWorkingCapital 302M -738M -380M -2 083M 1 143M 490M
otherNonCashItems 669M 349M -735M 281M 109M -64M
netCashProvidedByOperatingActivities 254M 965M -1 052M 3 325M 1 668M 1 107M
investmentsInPropertyPlantAndEquipment -154M -140M -124M -182M -154M -122M
acquisitionsNet -9M 11M 39M -8M -255M 234M
purchasesOfInvestments 0 0 -66M 0 0 0
salesMaturitiesOfInvestments 0 0 20M 659M 0 0
otherInvestingActivites -17M -37M -18M -713M -5M -35M
netCashUsedForInvestingActivites -180M -166M -149M -244M -414M 77M
debtRepayment -3 208M -1 938M -980M -8 829M -791M -102M
commonStockIssued 21M 27M 27M 20M 16M 36M
commonStockRepurchased -842M -809M -696M -138M -2 016M -484M
dividendsPaid -83M -75M -74M -76M -77M -68M
otherFinancingActivites 3 490M 1 886M 880M 7 833M 1 443M 46M
netCashUsedProvidedByFinancingActivities -622M -909M -843M -1 190M -1 425M -572M
effectOfForexChangesOnCash 7M -3M 2M 10M -9M 6M
netChangeInCash -542M -112M -2 043M 1 900M -180M 618M
cashAtEndOfPeriod 1 982M 2 524M 2 636M 4 678M 2 778M 2 958M
cashAtBeginningOfPeriod 2 524M 2 636M 4 679M 2 778M 2 958M 2 340M
operatingCashFlow 254M 965M -1 052M 3 325M 1 668M 1 107M
capitalExpenditure -154M -140M -124M -182M -154M -122M
freeCashFlow 100M 825M -1 176M 3 143M 1 514M 985M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q4
2024-02-07 ET (fiscal 2024 q3)
2023 q3
2023-11-01 ET (fiscal 2024 q2)
2023 q2
2023-08-02 ET (fiscal 2024 q1)
2023 q1
2023-05-08 ET (fiscal 2023 q4)
2022 q4
2023-02-01 ET (fiscal 2023 q3)
2022 q3
2022-11-01 ET (fiscal 2023 q2)
2022 q2
2022-08-03 ET (fiscal 2023 q1)
2022 q1
2022-05-05 ET (fiscal 2022 q4)
2021 q4
2022-02-02 ET (fiscal 2022 q3)
2021 q3
2021-11-01 ET (fiscal 2022 q2)
2021 q2
2021-08-04 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-07 21:10 ET
McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance
2024-02-01 13:00 ET
McKesson Corporation Declares Quarterly Dividend
2024-01-09 13:00 ET
McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-27 21:10 ET
McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference
2023-11-01 20:10 ET
McKesson Corporation Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance
2023-10-26 12:00 ET
McKesson Corporation Declares Quarterly Dividend
2023-09-27 20:10 ET
McKesson Corporation Announces Second Quarter Fiscal 2024 Earnings Release Date
2023-09-18 18:03 ET
Avricore Health announces HealthTab now supporting first Rexall Pharmacy walk-in clinic
2023-08-16 20:30 ET
Genpact Extends Relationship to Transform McKesson's Finance Operations for Enhanced Service and Competitive Growth
2023-08-02 20:10 ET
McKesson Corporation Reports Fiscal 2024 First Quarter Results
2023-07-24 12:00 ET
McKesson Raises Quarterly Dividend by 15% to $0.62 Per Share
2023-06-28 20:10 ET
 McKesson Corporation Announces First-Quarter Fiscal 2024 Earnings Release Date
2023-06-13 22:20 ET
McKesson Corporation Announces the Expiration and Results of Tender Offer for Any and All 3.796% Notes Due 2024
2023-06-13 20:05 ET
McKesson Corporation Announces Pricing Terms of Tender Offer for Any and All 3.796% Notes Due 2024
2023-06-07 13:00 ET
McKesson Corporation Commences Tender Offer for Any and All 3.796% Notes Due 2024
2023-05-08 20:10 ET
McKesson Corporation Reports Fiscal 2023 Fourth-Quarter and Full-Year Results and Raises Long-Term Segment Growth Targets
2023-04-27 12:00 ET
McKesson Corporation Declares Quarterly Dividend
2023-03-27 20:10 ET
McKesson Corporation Announces Fourth-quarter Fiscal 2023 Earnings Release Date
2023-03-20 18:30 ET
McKesson Medical-Surgical Government Solutions Awarded Federal Supply Schedule Medical Equipment and Supply Contract
2023-02-01 21:10 ET
McKesson Corporation Reports Fiscal 2023 Third-Quarter Results
2023-01-26 13:00 ET
McKesson Corporation Declares Quarterly Dividend
2022-12-28 21:10 ET
McKesson Corporation Announces Third-Quarter Fiscal 2023 Earnings Release Date
2022-11-01 20:10 ET
McKesson Corporation Reports Fiscal 2023 Second-Quarter Results and Raises Full-Year Guidance
2022-10-27 12:00 ET
McKesson Corporation Declares Quarterly Dividend
2022-09-29 20:10 ET
McKesson Corporation Extends Pharmaceutical Distribution Agreement With CVS Health
2022-09-19 12:36 ET
McKesson Signs Agreement to Acquire Rx Savings Solutions
2022-09-19 12:30 ET
McKesson Signs Agreement to Acquire Rx Savings Solutions
2022-09-13 20:05 ET
McKesson Names LeAnn B. Smith as Next Chief Human Resources Officer
2022-08-03 20:10 ET
McKesson Corporation Reports Fiscal 2023 First-Quarter Results
2022-07-25 12:00 ET
McKesson Raises Quarterly Dividend by 15% to $0.54 Per Share
2022-06-29 20:10 ET
McKesson Corporation Announces First Quarter Fiscal 2023 Earnings Release Date
2022-06-23 12:30 ET
McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical Research
2022-05-05 20:10 ET
McKesson Reports Fiscal 2022 Fourth-Quarter Results
2022-05-03 11:35 ET
Distributors Agree to Opioid Settlement With Washington State
2022-04-28 12:00 ET
McKesson Declares Quarterly Dividend
2022-04-07 12:00 ET
McKesson Corporation Completes Divestiture of UK Businesses, Announces Fourth Quarter Fiscal 2022 Earnings Release Date
2022-04-01 12:00 ET
McKesson’s Board of Directors Elects W. Roy Dunbar as New Director
2022-02-25 11:45 ET
Distributors Approve Opioid Settlement Agreement
2022-02-02 21:05 ET
McKesson Reports Fiscal 2022 Third-Quarter Results
2022-01-27 13:10 ET
McKesson Declares Quarterly Dividend
2022-01-18 22:10 ET
McKesson’s Board of Directors Elects James H. Hinton and Kathleen Wilson-Thompson as New Directors
2021-12-29 13:10 ET
McKesson Corporation Announces Third Quarter Fiscal 2022 Earnings Release Date and Participation in January Conference
2021-12-22 22:31 ET
Distributors Announce Extension of Opioid Settlement Sign-On Period, Participation of New Mexico
2021-12-20 11:00 ET
McKesson Corporation Enters Agreement to Sell its Austrian Business to Quadrifolia Management GmbH
2021-12-08 13:10 ET
McKesson Investor Day to Highlight Progress Against Growth Strategies and Long-Term Financial Targets
2021-12-01 13:10 ET
McKesson to Host Investor Day on December 8, 2021
2021-11-01 20:10 ET
McKesson Reports Fiscal 2022 Second-Quarter Results
2021-11-01 11:08 ET
McKesson Corporation Enters Agreement to Sell UK Businesses to AURELIUS
2021-10-28 12:10 ET
McKesson Declares Quarterly Dividend
2021-09-28 17:03 ET
Distributors Announce Settlement With Cherokee Nation
2021-09-27 20:10 ET
McKesson Corporation to Announce Second Quarter Fiscal 2022 Results on November 1, 2021
2021-09-07 12:23 ET
Mckesson’s Board of Directors Elects Dr. Richard H. Carmona as New Independent Director
2021-09-04 22:08 ET
Distributors Announce Proposed Opioid Settlement Will Proceed to Next Phase
2021-08-16 20:10 ET
McKesson to Host Investor Day on December 8, 2021
2021-08-04 20:05 ET
McKesson Reports Fiscal 2022 First-Quarter Results
2021-07-26 12:00 ET
McKesson Raises Quarterly Dividend by 12% to $0.47 Per Share
2021-07-22 20:45 ET
McKesson Corporation Announces Pricing and Upsizing of Tender Offer
2021-07-22 12:00 ET
McKesson Corporation Announces Early Tender Results and Intention to Increase the Tender Cap
2021-07-21 18:15 ET
Distributors Announce Proposed Opioid Settlement Agreement
2021-07-20 13:17 ET
Distributors Reach Opioid Settlement Agreement With New York State
2021-07-08 12:00 ET
McKesson Corporation Announces Offer to Purchase up to $500 Million Aggregate Principal Amount of Debt
2021-07-07 12:00 ET
McKesson Corporation Enters Agreement to Sell Certain European Businesses to the PHOENIX Group
2021-06-30 20:10 ET
McKesson Corporation to Announce First Quarter Fiscal 2022 Results on August 4, 2021
2021-05-06 20:05 ET
McKesson Reports Fiscal 2021 Fourth-Quarter and Full-Year Results
2021-04-29 20:10 ET
McKesson Declares Quarterly Dividend
2021-04-01 20:10 ET
McKesson Corporation to Announce Fourth Quarter Fiscal 2021 Results on May 6, 2021
2021-02-02 12:00 ET
McKesson Reports Fiscal 2021 Third-Quarter Results
2021-01-28 21:10 ET
McKesson Declares Quarterly Dividend
2020-12-28 21:10 ET
McKesson Corporation Announces Third Quarter Fiscal 2021 Earnings Release Date and Participation in January Conferences
2020-11-19 21:15 ET
McKesson Appoints Dr. Kelvin A. Baggett to Chief Impact Officer
2020-11-03 12:00 ET
McKesson Reports Fiscal 2021 Second-Quarter Results
2020-10-29 20:10 ET
McKesson Declares Quarterly Dividend
2020-10-19 11:00 ET
McKesson’s Board of Directors Elects Linda Mantia as New Independent Director
2020-10-05 20:10 ET
McKesson Corporation to Announce Second Quarter Fiscal 2021 Results on November 3, 2020
2020-08-14 17:59 ET
McKesson to Distribute Future COVID-19 Vaccines in Support of Operation Warp Speed
2020-08-03 11:00 ET
McKesson Reports Fiscal 2021 First-Quarter Results
2020-07-29 20:27 ET
McKesson Declares Quarterly Dividend July 29, 2020
2020-07-06 20:10 ET
McKesson Corporation to Announce First Quarter Fiscal 2021 Results on August 3, 2020
2020-07-01 20:10 ET
McKesson Realigns Organizational Structure to Better Serve Customers and Patients While Optimizing Growth
2020-06-04 20:15 ET
McKesson Appoints Tom Rodgers to Executive Vice President & Chief Strategy and Business Development Officer
2020-05-20 11:00 ET
McKesson Reports Fiscal 2020 Fourth-Quarter and Full-Year Results
2020-04-29 20:10 ET
McKesson Declares Quarterly Dividend April 29, 2020
2020-04-20 20:10 ET
McKesson Corporation to Announce Fourth Quarter Fiscal 2020 Results on May 20, 2020
2020-03-23 20:46 ET
McKesson Announces Bansi Nagji to Step Down as Executive Vice President, Chief Strategy and Business Development Officer
2020-03-17 20:10 ET
McKesson Updates Fiscal 2020 Guidance Following Completion of Change Healthcare Split-Off
2020-03-12 12:00 ET
McKesson Announces Final Results of Exchange Offer
2020-03-10 13:00 ET
McKesson Completes Split-off of Its Interest in Change Healthcare
2020-03-10 12:00 ET
McKesson Announces Preliminary Results of Exchange Offer
2020-03-05 22:50 ET
McKesson Sets Final Exchange Ratio of 11.4086 for Exchange Offer
2020-02-10 12:31 ET
McKesson Launches Exchange Offer to Split-Off Its Interest in Change Healthcare
2020-02-04 12:00 ET
McKesson Reports Fiscal 2020 Third Quarter Results
2020-01-31 14:00 ET
Coborn’s Taps McKesson High Volume Solutions to Centralize Prescription Fulfillment for Its Pharmacies
2020-01-29 21:10 ET
McKesson Declares Quarterly Dividend
2020-01-13 21:10 ET
McKesson to Present at the 38th Annual J.P. Morgan Healthcare Conference: Will Provide Company Overview and Review Updated Financial Outlook
2020-01-03 14:00 ET
McKesson Corporation to Announce Third Quarter Fiscal 2020 Results on February 4, 2020
2019-12-18 13:30 ET
McKesson Reaffirms Fiscal 2020 Guidance
2019-12-12 16:01 ET
McKesson Selected by Department of Veterans Affairs as Prime Pharmaceutical Provider
2019-12-12 09:00 ET
Walgreens Boots Alliance and McKesson to Create German Wholesale Joint Venture
2019-12-10 21:10 ET
McKesson to Host Sell-Side Analyst Meeting on December 18, 2019
2019-12-09 21:10 ET
McKesson Appoints Nancy Flores as Executive Vice President, Chief Information and Chief Technology Officer
2019-11-09 04:59 ET
McKesson (MCK) Alert: Johnson Fistel Announces Shareholder Class Action Against McKesson Corporation Survives Motion to Dismiss; Should Management be Held Accountable for Investors Losses?

SEC forms

Show financial reports only

SEC form 10
2024-02-08 00:00 ET
McKesson published news for 2023 q4
SEC form 8
2024-02-07 00:00 ET
McKesson published news for 2023 q4
SEC form 8
2024-02-07 00:00 ET
McKesson reported for 2023 q4
SEC form 10
2023-11-02 00:00 ET
McKesson published news for 2023 q3
SEC form 10
2023-11-01 17:34 ET
McKesson published news for 2023 q3
SEC form 8
2023-11-01 16:05 ET
McKesson reported for 2023 q3
SEC form 10
2023-08-02 17:30 ET
McKesson reported for 2023 q2
SEC form 6
2023-08-02 16:05 ET
McKesson published news for 2023 q2
SEC form 10
2023-08-02 00:00 ET
McKesson published news for 2023 q2
SEC form 8
2023-08-02 00:00 ET
McKesson published news for 2023 q2
SEC form 6
2023-07-25 08:33 ET
McKesson published news for 2023 q2
SEC form 6
2023-06-16 16:07 ET
McKesson published news for 2023 q1
SEC form 6
2023-06-07 09:09 ET
McKesson published news for 2023 q1
SEC form 10
2023-05-09 00:00 ET
McKesson published news for 2023 q1
SEC form 8
2023-05-08 00:00 ET
McKesson reported for 2023 q1
SEC form 6
2023-02-15 16:06 ET
McKesson published news for 2022 q4
SEC form 6
2023-02-06 14:26 ET
McKesson published news for 2022 q4
SEC form 10
2023-02-02 00:00 ET
McKesson reported for 2022 q4
SEC form 10
2023-02-01 17:36 ET
McKesson reported for 2022 q4
SEC form 6
2023-02-01 16:05 ET
McKesson published news for 2022 q4
SEC form 8
2023-02-01 00:00 ET
McKesson reported for 2022 q4
SEC form 6
2022-12-05 13:35 ET
McKesson published news for 2022 q3
SEC form 6
2022-11-07 08:56 ET
McKesson published news for 2022 q3
SEC form 10
2022-11-02 00:00 ET
McKesson reported for 2022 q3
SEC form 10
2022-11-01 17:37 ET
McKesson reported for 2022 q3
SEC form 6
2022-11-01 16:06 ET
McKesson published news for 2022 q3
SEC form 8
2022-11-01 00:00 ET
McKesson reported for 2022 q3
SEC form 6
2022-09-16 16:32 ET
McKesson published news for 2022 q2
SEC form 6
2022-09-13 16:10 ET
McKesson published news for 2022 q2
SEC form 6
2022-09-09 15:59 ET
McKesson published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
McKesson reported for 2022 q2
SEC form 10
2022-08-03 17:35 ET
McKesson reported for 2022 q2
SEC form 6
2022-08-03 16:06 ET
McKesson published news for 2022 q2
SEC form 8
2022-08-03 00:00 ET
McKesson reported for 2022 q2
SEC form 6
2022-07-26 18:51 ET
McKesson published news for 2022 q2
SEC form 6
2022-07-26 18:51 ET
McKesson published news for 2022 q2
SEC form 6
2022-07-26 18:50 ET
McKesson published news for 2022 q2
SEC form 6
2022-07-26 18:50 ET
McKesson published news for 2022 q2
SEC form 6
2022-07-26 18:50 ET
McKesson published news for 2022 q2
SEC form 6
2022-07-26 18:49 ET
McKesson published news for 2022 q2
SEC form 6
2022-07-26 18:45 ET
McKesson published news for 2022 q2
SEC form 6
2022-07-25 16:41 ET
McKesson published news for 2022 q2
SEC form 6
2022-06-22 12:32 ET
McKesson published news for 2022 q1
SEC form 6
2022-06-09 16:11 ET
McKesson published news for 2022 q1
SEC form 6
2022-05-11 16:53 ET
McKesson published news for 2022 q1
SEC form 10
2022-05-09 08:15 ET
McKesson reported for 2022 q1
SEC form 10
2022-05-09 00:00 ET
McKesson reported for 2022 q1
SEC form 6
2022-05-05 16:09 ET
McKesson published news for 2022 q1
SEC form 8
2022-05-05 00:00 ET
McKesson reported for 2022 q1
SEC form 6
2022-04-29 16:42 ET
McKesson published news for 2022 q1
SEC form 6
2022-04-01 08:19 ET
McKesson published news for 2022 q1
SEC form 6
2022-02-25 08:06 ET
McKesson published news for 2021 q4
SEC form 6
2022-02-22 16:08 ET
McKesson published news for 2021 q4
SEC form 10
2022-02-03 00:00 ET
McKesson published news for 2021 q4
SEC form 10
2022-02-02 17:41 ET
McKesson published news for 2021 q4
SEC form 6
2022-02-02 16:08 ET
McKesson published news for 2021 q4
SEC form 8
2022-02-02 00:00 ET
McKesson published news for 2021 q4
SEC form 6
2022-01-21 17:26 ET
McKesson published news for 2021 q4
SEC form 6
2022-01-21 17:25 ET
McKesson published news for 2021 q4
SEC form 6
2022-01-18 17:11 ET
McKesson published news for 2021 q4
SEC form 10
2021-11-02 00:00 ET
McKesson published news for 2021 q3
SEC form 10
2021-11-01 17:41 ET
McKesson published news for 2021 q3
SEC form 6
2021-11-01 16:10 ET
McKesson published news for 2021 q3
SEC form 8
2021-11-01 00:00 ET
McKesson published news for 2021 q3
SEC form 6
2021-10-06 16:10 ET
McKesson published news for 2021 q3
SEC form 6
2021-09-16 16:10 ET
McKesson published news for 2021 q2
SEC form 6
2021-09-13 10:19 ET
McKesson published news for 2021 q2
SEC form 6
2021-09-08 15:45 ET
McKesson published news for 2021 q2
SEC form 6
2021-09-07 08:26 ET
McKesson published news for 2021 q2
SEC form 6
2021-08-18 08:37 ET
McKesson published news for 2021 q2
SEC form 6
2021-08-12 16:06 ET
McKesson published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
McKesson published news for 2021 q2
SEC form 10
2021-08-04 17:44 ET
McKesson published news for 2021 q2
SEC form 6
2021-08-04 16:13 ET
McKesson published news for 2021 q2
SEC form 8
2021-08-04 00:00 ET
McKesson published news for 2021 q2
SEC form 6
2021-07-26 16:14 ET
McKesson published news for 2021 q2
SEC form 6
2021-07-02 08:32 ET
McKesson published news for 2021 q2
SEC form 6
2021-06-08 16:11 ET
McKesson published news for 2021 q1
SEC form 10
2021-05-12 16:09 ET
McKesson published news for 2021 q1
SEC form 10
2021-05-12 00:00 ET
McKesson published news for 2021 q1
SEC form 6
2021-05-06 16:09 ET
McKesson published news for 2021 q1
SEC form 8
2021-05-06 00:00 ET
McKesson published news for 2021 q1
SEC form 6
2021-04-19 16:23 ET
McKesson published news for 2021 q1
SEC form 6
2021-04-02 12:46 ET
McKesson published news for 2021 q1
SEC form 10
2021-02-02 16:04 ET
McKesson published news for 2020 q4
SEC form 6
2021-02-02 07:06 ET
McKesson published news for 2020 q4
SEC form 6
2020-12-03 16:06 ET
McKesson published news for 2020 q3
SEC form 10
2020-11-03 09:07 ET
McKesson published news for 2020 q3
SEC form 6
2020-11-03 07:06 ET
McKesson published news for 2020 q3
SEC form 6
2020-10-27 18:58 ET
McKesson published news for 2020 q3
SEC form 6
2020-10-19 07:08 ET
McKesson published news for 2020 q3